Lipoprotein(a) and plasma lipids in 429 old to very old subjects: Importance as risk factor, influence of nutrition and lifestyle;Lipoprotein(a) und Plasma-Lipide bei 429 Betagten und Hochbetagten: Bedeutung als Risikofaktor, Einfluss von Ernahrung und Lebensstil

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 35, 1996, Pages 1487-1494

  Heinimann, K ^a   Stahelin H B ^a   Perrig Chiello, P ^b   Perrig, W O ^b   Ehrsam, K ^c   Meier, B ^b   Krings, F ^b  

^a Geriatrische Universitatsklinik   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOPROTEIN A;

AGED; AGING; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; LIFE EXPECTANCY; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; ANTHROPOMETRY; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; LIFE EXPECTANCY; LIFE STYLE; LIPIDS; LIPOPROTEIN(A); LONGITUDINAL STUDIES; MALE; NUTRITION PHYSIOLOGY; RISK FACTORS; VITAMINS;

EID: 0029788324     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Berg K: A new serum type system in man: the Lp system. Acta Path Microbiol Scand 1963; 59: 369-382.
2. Berg K: Lp(a) lipoprotein: an overview. Chem Phys Lipids 1994; 67/68: 9-16.
3. Scanu AM, Fless GM: Lipoprotein(a): heterogeneity and biological relevance. J Clin Invest 1991; 85: 1709-1715.
4. Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G: Changes of genetic apolipoprotein phenotypes caused by liver transplantation. J Clin Invest 1989; 83: 137-142.
5. Berg K: Twin research in coronary heart disease. In: Gedda L, Parisi P, Nance WE (Hrsg): Twin research 3: epidemiological and clinical studies. New York: Alan R Liss, 1981: 117-130.
6. Lamon-Fava S, Jimenez D, Christian JC, Fabsitz RR, Reed T et al.: The NHLBI twin study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 1991; 91: 97-106.
7. Gavish D, Azrolan N, Breslow JL: Plasma Lp(a) concentration is inversly correlated with ratio of kringle IV/kringle V encoding domains in the apo(a) gene. J Clin Invest 1989; 84: 4171-4174.
8. Gaubatz JW, Ghanem KJ, Guevara J Jr, Nava ML, Patsch W, Alorrisett JD: Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 1990: 31: 603-613.
9. Scanu AM: Lipoprotein(a): genetically determined cardiovascular pathogen in search of a function. J Lab Clin Med 1990; 116: 142-146.
10. Miles LA, Saber-Tehrani M, Radahd S: A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989; 339: 301-303.
11. Malekpour A, Saber-Tehrani M, Radahd S: Lipoprotein(a): structure, properties and clinical interest. Lab Med 1993; 24: 31-35.
12. Hajjar KA, Gavish D, Breslow JL, Nachman RL: Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-305.
13. Scanu AM: Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA 1992; 267: 3326-3329.
14. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kantz JA, Gotto AM: Association of levels of lipoprotein(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-765.
15. Hoefler L, Harnoncourt F, Paschke E, Mitrl W, Pfeiffer KH, Kostner GM: Lipoprotein(a): a risk factor for myocardial infarction. Arteriosclerosis 1988; 8: 398-401.
16. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G: Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23.
17. Genest J Jr, Jenner JL, McNamara JR, Ordovas JM, Silberman SR: Prevalence of lipoprotein(a) excess in coronary artery disease. Am J Cardiol 1991; 67: 1039-1045.
18. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H: Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301: 1248-1251.
19. Genest J Jr, Martin-Munley SS, McNamara JR: Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85: 2015-2033.
20. Schäfer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Odrovas JM et al.: Lipoprotein(a) levels and risk of coronary heart disease in men: the lipid research clinics coronary primary prevention trial. JAMA 1994; 271: 999-1003.
21. Perrig-Chiello P, Perrig WJ, Stähelin HB, Krebs-Roubicek E, Ehrsam R: Wohlbefinden, Gesundheit und Autonomie im Alter: die Basler IDA-Studie (Interdisziplinäre Altersstudie). Z f Gerontol Geriat 1996; 29: 95-109.
22. Widmer LK, Stähelin HB, Nissen C, da Silva A: Venen-, Arterien-Krankheiten, koronare Herzkrankheit bei Berufstätigen. Bern: Hans Huber Verlag, 1981.
23. Stähelin HB, Gey KF, Eichholzer M, Lüdin E, Bernasconi F et al.: Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. Am J Epidemiol 1991; 133: 766-775.
24. Cillery P, Arthuis P, Cuperlier C, Circand R: Rate nephelometric assay of serum lipoprotein(a). Clin Chem 1993; 39: 503-508.
25. Hess D, Keller HE, Oberlin B, Bonfanti R, Schüep W: Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. Int J Vitam Nutr Res 1991; 61: 232-238.
26. Brubacher G, Vuilleumier JP: Vitamin C. In: Curtius HCh, Roth M (Hrsg): Clinical biochemistry. Berlin: De Gruyter, 1974.
27. Bassey EJ, Short AH: A new method for measuring power output in a single leg extension: feasibility, reliability and validity. Eur J Appl Physiol 1990; 60: 385-390.
28. Bassey EJ, Tay G, West F: A comparison between power output in a single leg extension and in weight-bearing activities of brief duration such as stair-running in man. J Physiol (Lond) 1990; 427: 12.
29. Bassey EJ, Fiatarone MA, O'Neill EF, Kelly M, Evans WJ, Lipsitz LW: Leg extensor power and functional performance in very old men and women. Clin Sci 1992; 82: 321-327.
30. Lohman TG: Anthropometric standardization reference manual. Champaign: Human Kinetic Books, 1991.
31. Williams DP, Going SB, Lohman TG, Hewitt MJ, Haber AE: Estimation of body fat from skinfold thickness in middle-aged and older men and women: a multiple component approach. Am J Hum Biol 1992; 4: 595-605.
32. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP: Effects of age, sex and menopausal status on plasma lipoprotein(a) levels. Circulation 1993; 87: 1135-1141.
33. Rader DJ, Brewer HB: Lipoprotein(a): clinical approach to a unique atherogenic lipoprotein. JAMA 1992; 267: 1109-1112.
34. Simons L, Friedlander Y, Simons J, McCallum J: Lipoprorein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study. Atherosclerosis 1993; 99: 87-95.
35. Knapp RG, Schreiber PJ, Sutherland SE, Keil JE, Gilbert GE et al.: Serum lipoprotein(a) levels in elderly black and white men in the Charleston heart study. Clin Genet 1993; 44: 225-231.
36. Berg K, Ro OC: Lp(a) level and longevity. Ann Genet 1991; 34: 264-269.
37. Eckhardt H, Borchelt M, Niezcaj R, Steinhagen-Thiessen E: Abhängigkeit der Korrelation zwischen Alter und LDL bei älteren Frauen der Berliner Altersstudie von der Höhe des Serum-HDL-Wertes. Geriat Forsch 1994; 4: 117-122.
38. Richter V, Rassoul F, Opitz F, Purschwitz K, Rotzsch W: Altersabhängigkeit von Lipidstoffwechsel-Parametern: Screening-Untersuchungen auf Bevölkerungsebene. Z Gerontol 1993; 26: 260-264.
39. Lui AC, Lawn RM, Verstuyft JG, Rubin EM: Human apolipoprotein A-1 prevents atherosclerosis associated with apolipoprotein(a) in transgenic mice. J Lipid Res 1994; 35: 2263-2267.
40. Nestel P, Noakes M, Belling B, McArthur R, Clifton P et al.: Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029-1036.